O	0	8	Reducing
O	9	18	vasomotor
O	19	27	symptoms
O	28	32	with
B-intervention	33	44	acupuncture
O	45	47	in
O	48	54	breast
O	55	61	cancer
O	62	70	patients
O	71	78	treated
O	79	83	with
O	84	92	adjuvant
O	93	102	tamoxifen
O	102	103	:
O	104	105	a
O	106	116	randomized
O	117	127	controlled
O	128	133	trial
O	133	134	.

O	135	137	To
O	138	146	evaluate
O	147	151	true
O	152	163	acupuncture
O	164	166	to
B-control	167	174	control
I-control	175	186	acupuncture
O	187	188	(
O	188	192	CTRL
O	192	193	)
O	194	195	(
O	195	198	non
O	198	199	-
O	199	208	insertive
O	209	220	stimulation
O	221	223	at
O	224	227	non
O	227	228	-
O	228	239	acupuncture
O	240	246	points
O	246	247	)
O	248	250	in
B-eligibility	251	257	breast
I-eligibility	258	264	cancer
I-eligibility	265	273	patients
I-eligibility	274	281	treated
I-eligibility	282	286	with
I-eligibility	287	295	adjuvant
I-eligibility	296	305	tamoxifen
I-eligibility	306	315	suffering
I-eligibility	316	320	from
I-eligibility	321	324	hot
I-eligibility	325	332	flushes
I-eligibility	333	336	and
I-eligibility	337	346	sweatings
O	346	347	.

B-total-participants	348	354	Eighty
I-total-participants	354	355	-
I-total-participants	355	359	four
O	360	368	patients
O	369	373	were
O	374	384	randomized
O	385	387	to
O	388	395	receive
O	396	402	either
O	403	407	true
O	408	419	acupuncture
O	420	422	or
O	423	427	CTRL
O	428	433	twice
O	434	435	a
O	436	440	week
O	441	444	for
O	445	446	5
O	447	452	weeks
O	452	453	.

B-total-participants	454	461	Seventy
I-total-participants	461	462	-
I-total-participants	462	466	four
O	467	475	patients
O	476	480	were
O	481	488	treated
O	489	498	according
O	499	501	to
O	502	505	the
O	506	514	protocol
O	514	515	.

O	516	518	In
O	519	522	the
O	523	527	true
O	528	539	acupuncture
O	540	545	group
B-iv-bin-percent	546	548	42
I-iv-bin-percent	548	549	%
O	550	551	(
B-iv-bin-abs	551	553	16
O	553	554	/
B-intervention-participants	554	556	38
O	556	557	)
O	558	566	reported
B-outcome	567	579	improvements
I-outcome	580	582	in
I-outcome	583	586	hot
I-outcome	587	594	flushes
I-outcome	595	600	after
I-outcome	601	602	6
I-outcome	603	608	weeks
O	609	617	compared
O	618	620	to
B-cv-bin-percent	621	623	47
I-cv-bin-percent	623	624	%
O	625	626	(
B-cv-bin-abs	626	628	17
O	628	629	/
B-control-participants	629	631	36
O	631	632	)
O	633	635	in
O	636	639	the
O	640	644	CTRL
O	645	650	group
O	651	652	(
O	652	654	95
O	654	655	%
O	656	658	CI
O	658	659	,
O	660	661	-
O	661	663	28
O	664	666	to
O	667	669	18
O	669	670	%
O	670	671	)
O	671	672	.

O	673	677	Both
O	678	684	groups
O	685	693	reported
O	694	705	improvement
O	706	715	regarding
B-outcome	716	724	severity
I-outcome	725	728	and
I-outcome	729	740	frequencies
I-outcome	741	743	in
I-outcome	744	747	hot
I-outcome	748	755	flushes
I-outcome	756	759	and
I-outcome	760	769	sweatings
O	770	773	but
O	774	776	no
O	777	788	statistical
O	789	799	difference
O	800	803	was
O	804	809	found
O	810	817	between
O	818	821	the
O	822	828	groups
O	828	829	.

O	830	832	In
O	833	834	a
O	835	846	subanalysis
O	847	856	regarding
O	857	860	the
B-outcome	861	869	severity
I-outcome	870	872	of
I-outcome	873	882	sweatings
I-outcome	883	885	at
I-outcome	886	891	night
O	892	893	a
O	894	907	statistically
O	908	919	significant
O	920	930	difference
O	931	932	P
O	933	934	=
O	935	936	0
O	936	937	.
O	937	939	03
O	940	943	was
O	944	949	found
O	950	952	in
O	953	956	the
O	957	961	true
O	962	973	acupuncture
O	974	979	group
O	979	980	.

O	981	987	Former
O	988	998	experience
O	999	1001	of
O	1002	1006	true
O	1007	1018	acupuncture
O	1019	1022	did
O	1023	1026	not
O	1027	1036	influence
O	1037	1040	the
O	1041	1051	perception
O	1052	1054	of
O	1055	1059	true
O	1060	1071	acupuncture
O	1072	1074	or
O	1075	1079	CTRL
O	1079	1080	.

O	1081	1083	No
O	1084	1095	significant
O	1096	1107	differences
O	1108	1110	in
B-outcome	1111	1119	hormonal
I-outcome	1120	1126	levels
O	1127	1131	were
O	1132	1137	found
O	1138	1144	before
O	1145	1148	and
O	1149	1154	after
O	1155	1164	treatment
O	1164	1165	.

O	1166	1168	In
O	1169	1179	conclusion
O	1179	1180	,
O	1181	1191	convincing
O	1192	1196	data
O	1197	1201	that
O	1202	1206	true
O	1207	1218	acupuncture
O	1219	1221	is
O	1222	1226	more
O	1227	1236	effective
O	1237	1241	than
O	1242	1246	CTRL
O	1247	1249	in
O	1250	1258	reducing
O	1259	1268	vasomotor
O	1269	1277	symptoms
O	1278	1280	is
O	1281	1286	still
O	1287	1294	lacking
O	1294	1295	.

O	1296	1299	Our
O	1300	1305	study
O	1306	1311	shows
O	1312	1316	that
O	1317	1321	both
O	1322	1326	true
O	1327	1330	and
O	1331	1335	CTRL
O	1336	1342	reduce
O	1343	1352	vasomotor
O	1353	1361	symptoms
O	1362	1364	in
O	1365	1371	breast
O	1372	1378	cancer
O	1379	1387	patients
O	1388	1395	treated
O	1396	1400	with
O	1401	1409	adjuvant
O	1410	1419	tamoxifen
O	1419	1420	.
